Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW concomitant use with Bexsero in infants and toddlers
2017-004520-30Phase 3Unknown
- Sponsor
- Sanofi
- Start
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of meningococcal A conjugate vaccine in meningococcal disease (2 arms), sponsored by Sanofi. Primary endpoint: hSBA seroprotection response for serogroups A, C, Y, and W. Status: unknown.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-004520-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004520-30.